학술논문
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial
Document Type
Article
Author
Source
In Lung Cancer May 2024 191
Subject
Language
ISSN
0169-5002